FourThought Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

FourThought Financial Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.25M	Buy	10,684 +470	+5%	+$255K	0.45%	63
2025 Q4	$5.92M	Buy	10,214 +2	+0%	+$1.13K	0.5%	56
2025 Q3	$4.95M	Buy	10,212 +58	+0.6%	+$27K	0.44%	66
2025 Q2	$4.12M	Buy	10,154 +371	+4%	+$155K	0.41%	68
2025 Q1	$4.87M	Buy	9,783 +243	+3%	+$132K	0.51%	57
2024 Q4	$4.96M	Buy	9,540 +35	+0.4%	+$19.2K	0.52%	56
2024 Q3	$5.88M	Buy	9,505 +55	+0.6%	+$32.6K	0.7%	51
2024 Q2	$5.23M	Buy	9,450 +149	+2%	+$85.4K	0.67%	49
2024 Q1	$5.41M	Sell	9,301 -114	-1%	-$64K	0.62%	47
2023 Q4	$5M	Sell	9,415 -276	-3%	-$134K	0.63%	48
2023 Q3	$4.91M	Buy	9,691 +2,023	+26%	+$1.08M	0.69%	45
2023 Q2	$4M	Buy	7,668 +1,239	+19%	+$669K	0.53%	56
2023 Q1	$3.71M	Buy	6,429 +952	+17%	+$537K	0.51%	60
2022 Q4	$3.02M	Buy	+5,477	New	+$2.9M	0.44%	66

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FourThought Financial Partners's TMO Position: Q1 2026 in Review

FourThought Financial Partners increased its Thermo Fisher Scientific (TMO) stake by 4.6% in Q1 2026, buying an estimated $255K and bringing the position to 10,684 shares worth $5.25M. The position accounts for 0.45% of the portfolio, ranked #63.

FourThought Financial Partners first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.92M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

FourThought Financial Partners held 10,684 shares of Thermo Fisher Scientific worth $5.25M as of Q1 2026.
FourThought Financial Partners bought 470 Thermo Fisher Scientific shares in Q1 2026, an estimated $255K.
Thermo Fisher Scientific made up 0.45% of FourThought Financial Partners's portfolio in Q1 2026, its #63 holding.
FourThought Financial Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
FourThought Financial Partners's Thermo Fisher Scientific position peaked at $5.92M in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.